IGFBP7 and HIV-1 infection: For comparison, TRIM5α of AGM strongly restricts HIV-1 infection [8,24,25] (~20-fold in our experiments, Figure 3B), while human TRIM5α only modestly inhibits HIV-1 infection by about 50% [8,25].